CFA Pharma: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CFA Pharma
Largest movements
- Tangible fixed assets +€118,463
up €118,463 (+90.9%), from €130,288 to €248,751
of which Land and buildings: +€136,463
- Receivables within one year +€18,651
up €18,651 (+7.4%), from €251,780 to €270,431
of which Other amounts receivable: +€151,268
- Debts after one year +€107,871
up €107,871 (+68.0%), from €158,599 to €266,470
of which Financial debts: +€107,871
- Current portion of long-term debt +€8,908
up €8,908 (+29.8%), from €29,846 to €38,753
- Trade debts +€7,478
up €7,478 (+19.6%), from €38,108 to €45,587
- Other debts +€6,000
up €6,000 (+60.0%), from €10,000 to €16,000
- Depreciation +€9,673
up €9,673 (+53.7%), from €18,000 to €27,673
- Taxes +€4,331
up €4,331 (+2085.8%), from €208 to €4,539
- Financial charges +€3,340
up €3,340 (+47.9%), from €6,974 to €10,314
- Other operating charges +€1,740
up €1,740 (+151.3%), from €1,150 to €2,890
- Gross operating margin -€584
down €584 (-1.1%), from €52,742 to €52,159
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €389,747 | €525,286 | +€135,539 | +34.8% |
| Fixed assets | 21/28 | €130,288 | €248,751 | +€118,463 | +90.9% |
| Tangible fixed assets | 22/27 | €130,288 | €248,751 | +€118,463 | +90.9% |
| Land and buildings | 22 | - | €136,463 | +€136,463 | |
| Other tangible fixed assets | 26 | €130,288 | €112,288 | -€18,000 | -13.8% |
| Current assets | 29/58 | €259,459 | €276,536 | +€17,076 | +6.6% |
| Amounts receivable within one year | 40/41 | €251,780 | €270,431 | +€18,651 | +7.4% |
| Trade receivables | 40 | €171,881 | €39,264 | -€132,616 | -77.2% |
| Other amounts receivable | 41 | €79,899 | €231,167 | +€151,268 | +189.3% |
| Cash at bank and in hand | 54/58 | €7,679 | €6,105 | -€1,575 | -20.5% |
| Total equity and liabilities | 10/49 | €389,747 | €525,286 | +€135,539 | +34.8% |
| Equity | 10/15 | €153,194 | €153,937 | +€743 | +0.5% |
| Contributions | 10/11 | €28,000 | €28,000 | = | 0.0% |
| Reserves | 13 | €97,165 | €97,907 | +€743 | +0.8% |
| Non-distributable reserves | 130/1 | €2,800 | €2,800 | = | 0.0% |
| Reserves not available under the articles | 1311 | €2,800 | €2,800 | = | 0.0% |
| Distributable reserves | 133 | €94,365 | €95,107 | +€743 | +0.8% |
| Profit (loss) carried forward | 14 | €28,030 | €28,030 | = | 0.0% |
| Amounts payable | 17/49 | €236,553 | €371,349 | +€134,796 | +57.0% |
| Amounts payable after more than one year | 17 | €158,599 | €266,470 | +€107,871 | +68.0% |
| Financial debts | 170/4 | €148,599 | €256,470 | +€107,871 | +72.6% |
| Trade debts | 175 | €10,000 | €10,000 | = | 0.0% |
| Amounts payable within one year | 42/48 | €77,954 | €104,879 | +€26,925 | +34.5% |
| Current portion of amounts payable after more than one year | 42 | €29,846 | €38,753 | +€8,908 | +29.8% |
| Trade debts | 44 | €38,108 | €45,587 | +€7,478 | +19.6% |
| Suppliers | 440/4 | €38,108 | €45,587 | +€7,478 | +19.6% |
| Taxes, remuneration and social security | 45 | - | €4,539 | +€4,539 | |
| Taxes | 450/3 | - | €4,539 | +€4,539 | |
| Other amounts payable | 47/48 | €10,000 | €16,000 | +€6,000 | +60.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18,000 | €27,673 | +€9,673 | +53.7% |
| Other operating charges | 640/8 | €1,150 | €2,890 | +€1,740 | +151.3% |
| Gross operating margin | 9900 | €52,742 | €52,159 | -€584 | -1.1% |
| Operating profit (loss) | 9901 | €33,592 | €21,596 | -€11,996 | -35.7% |
| Financial income | 75/76B | €246 | €0 | -€245 | -99.9% |
| Recurring financial income | 75 | €246 | €0 | -€245 | -99.9% |
| Financial charges | 65/66B | €6,974 | €10,314 | +€3,340 | +47.9% |
| Recurring financial charges | 65 | €6,974 | €10,314 | +€3,340 | +47.9% |
| Profit (loss) for the period before taxes | 9903 | €26,863 | €11,282 | -€15,582 | -58.0% |
| Income taxes | 67/77 | €208 | €4,539 | +€4,331 | +2085.8% |
| Profit (loss) for the period | 9904 | €26,656 | €6,743 | -€19,913 | -74.7% |
| Profit (loss) for the period to be appropriated | 9905 | €26,656 | €6,743 | -€19,913 | -74.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.